The Crohn's & Colitis Foundation is deeply concerned about the methotrexate shortage, which is a critical treatment for IBD. We are addressing the shortage with our industry partners and with the FDA.
Speakers:
Joel Rosh, MD
Jami Kinnucan, MD
David Choi, PharmD
Date: 4.21.2023
Facebook Comments